StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$57.07+0.77 (+1.37%)

Close on Nov 18, 2026Market cap $7.44BP/E –Yield –

10x Genomics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

10x Genomics's enterprise value was $7.37B on Nov 11, 2026, against $1.84B a year earlier. Over the last 5 years it ranged from $617.95M to $15.66B, with a median of $3.67B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.37B+381.0%
2025Dec 31, 2025$1.53B+16.1%
2024Dec 31, 2024$1.32B-78.5%
2023Dec 29, 2023$6.14B+67.7%
2022Dec 30, 2022$3.66B-76.6%
2021Dec 31, 2021$15.66B+10.9%
2020Dec 31, 2020$14.12B+105.2%
2019Dec 31, 2019$6.88B–

More 10x Genomics figures

See a number that looks wrong?